JP Morgan Maintains Overweight on NOV, Lowers Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Arun Jayaram maintains an Overweight rating on NOV but lowers the price target from $23 to $22.
October 03, 2024 | 4:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan has maintained its Overweight rating on NOV but has reduced the price target from $23 to $22, indicating a slightly less optimistic outlook.
The Overweight rating suggests continued confidence in NOV's performance, but the lowered price target indicates a slight reduction in expected upside. This mixed signal may lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100